Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-18

Clinical Trial Update: Cognitive Reserve-building Activities in Multiple Sclerosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating cognitive reserve-building activities for people with multiple sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Multiple Sclerosis | Phase 2 | Status: COMPLETED